SARS-CoV-2 (COVID-19) Severe Pneumonia
1 clinical trials · Condition
◉ Watch SARS-CoV-2 (COVID-19) Severe Pneumonia
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19 (NCT04412668) | aTyr Pharma, Inc. | 2020-06-04 |
Track SARS-CoV-2 (COVID-19) Severe Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.